Last updated on July 2018

Plasma Biomarkers C-RAC ICORG 12-27 V1

Brief description of study

This is an exploratory, translational, non-interventional and multi-centre clinical study.

Detailed Study Description

Cohort A will consist of 100 CRAC patients with stage II/III resectable disease due for adjuvant chemotherapy.

Cohort B will consist of 30 patients with stage II resectable disease for observation only.

Both cohorts will have a follow up period of up to 2 years, post chemotherapy for cohort A and post resection for cohort B.

Clinical Study Identifier: NCT02050737

Find a site near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.